Small intestinal bacterial overgrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis

Scandinavian Journal of Gastroenterology

Volumn 36, Issue 1, 2001, Pages 92-96

  Chang, C S ^a   Yang, S S ^a   Kao, C H ^a   Yeh, H Z ^a   Chen, G H ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Complements; Liver cirrhosis; Reticuloendothelial system; Spontaneous bacterial peritonitis; Total ascitic protein

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; PROTEIN;

ADULT; AGED; ARTICLE; ASCITES; BACTERIAL OVERGROWTH; BACTERIAL PERITONITIS; BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; HOST RESISTANCE; HUMAN; HUMAN TISSUE; HYDROGEN BREATH TEST; INTESTINE FLORA; LIVER CIRRHOSIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; RISK FACTOR; SMALL INTESTINE;

EID: 0035133318     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520150218110     Document Type: Article

References (42)

1. Spontaneous bacterial peritonitis in cirrhosis: Predictive factors of infection resolution and survival in patients treated with cefotaxime
2. Spontaneous bacterial peritonitis: An update on evaluation, management, and prevention
3. Spontaneous bacterial peritonitis: Clinical and microbiological study of 233 episodes
4. Prevalence and prognostic significance of bacterascites in cirrhosis with ascites
5. Spontaneous bacterial peritonitis in patients with hepatitis B-related cirrhosis and hepatocellular carcinoma
6. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis
7. Impaired monocyte function in liver cirrhosis
8. Complement and liver cell function in 53 patients with liver disease
9. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis
10. 2-breath tests predict endotoxemia, infection or survival in alcoholic liver cirrhosis?
11. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial
12. Transection of the esophagus for bleeding esophageal varices
13. Culture-negative neutrocytic ascites: A variant of spontaneous bacterial peritonitis
14. Bacterial overgrowth
15. Breath hydrogen testing in bacterial overgrowth of the small intestine
16. Phagocytosis of the reticuloendothelial system in diabetes mellitus
17. Phagocytosis of the reticuloendothelial system in systemic lupus erythematosus
18. Problems of bacterial infection in patients with liver disease
19. 4 breath tests
20. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis
21. Phagocytosis of microorganisms
22. Complement deficiency states
23. Serum complement in chronic liver disease
24. Complement levels in patients with hepatic dysfunction
25. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis
26. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites
27. Selective intestinal decontamination prevents spontaneous bacterial peritonitis
28. Complement activation in chronic liver disease
29. Circulating immune complexes and complement concentrations in patients with alcoholic liver disease
30. Current concepts in immunology: Genetics and biosynthesis of complement proteins
31. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality
32. Selective intestinal decontamination increases serum and ascitic fluid C3 levels in cirrhosis
33. Local and systemic complement activity in small intestinal bacterial overgrowth
34. Kupffer cell number is normal, but their lysozyme content is reduced in alcoholic liver disease
35. Host mechanisms which act to remove bacteria from the blood stream
36. Plasma lysozyme level and reticuloendothelial system function in human liver disease
37. Reticuloendothelial phagocytic function in human liver disease and its relationship to liver haemolysis
38. Reticuloendothelial function in patients with alcoholic liver cirrhosis
39. Kupffer cell phagocytosis in relation to BSP clearance in liver and inflammatory bowel diseases
40. Study of the reticuloendothelial phagocytic capacity in patients with cholestasis
41. Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis
42. Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotic with low ascitic fluid protein levels